Indivior PLC
Indivior PLC (IZQVF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
izqvf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Indivior PLCYou IZQVF | $2.9B | 18.67x | -53.7% | $2.00 |
 Alfresa Holdings Corporation ARHCF | $2.2B | 8.15x | -79.8% | $231.09 |
 Ascentage Pharma Group International ASPHF | $1.7B | N/A | — | -$3.40 |
 Digital Utilities Ventures, Inc. DUTV | $1.9B | N/A | — | -$0.00 |
 Karo Pharma AB (publ) KARBF | $1.5B | N/A | — | — |
 Kaken Pharmaceutical Co., Ltd. KKPCF | $1.0B | 72.51x | +79.8% | $56.91 |
 Mithra Pharmaceuticals S.A. MITPF | $1.6B | N/A | — | -$2.51 |
Industry Average 2 peers with valid PE | — | 40.33x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Indivior PLC (IZQVF) measures how much investors pay for each dollar of the company's trailing earnings. IZQVF's current PE ratio of 18.67x is calculated by dividing its stock price of $20.97 by its TTM earnings per share of $2.00.
Frequently asked questions
IZQVF pe ratio · 6 questionsIZQVF's current PE ratio is 18.67x as of 2026-06-09, based on a stock price of $20.97 and TTM EPS of $2.00. Data sourced from Financial Modeling Prep via IZQVF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Indivior PLC SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09